PALO ALTO, Calif.--(BUSINESS WIRE)--StemCells, Inc. (NASDAQ:STEM) today announced that it has accepted an invitation by the California Institute of Regenerative Medicine (CIRM) to present on Batten Disease at the upcoming meeting of CIRM’s Independent Citizens Oversight Committee (ICOC). At the meeting, Ann Tsukamoto, Ph.D., the Company’s Chief Operating Officer, and Stephen Huhn, M.D., F.A.C.S., F.A.A.P., Vice President and Head of the Company’s CNS Program, will describe the Company’s proprietary human neural stem cells and their potential application to Batten Disease, a fatal neurodegenerative disorder. The presentation, entitled Spotlight on Batten Disease, will take place at the Arrillaga Alumni Center, McCaw Hall, on the campus of Stanford University, Palo Alto, on Wednesday, August 13, 2008, at 8:15 a.m. PDT. The presentation is one of a series of educational events organized by CIRM to educate the ICOC and the general public about specific diseases or medical conditions that could be treated with stem cells or related research.
